|
Rabkin, Judith G; Wagner, Glenn J; McElhiney, Martin C et al. (2004) Testosterone versus fluoxetine for depression and fatigue in HIV/AIDS: a placebo-controlled trial. J Clin Psychopharmacol 24:379-85
|
|
Daly, R C; Schmidt, P J; Roca, C A et al. (2001) Testosterone's effects not limited to mood. Arch Gen Psychiatry 58:403-4
|
|
Rabkin, J G; Wagner, G J; Rabkin, R (2000) A double-blind, placebo-controlled trial of testosterone therapy for HIV-positive men with hypogonadal symptoms. Arch Gen Psychiatry 57:141-7; discussion 155-6
|
|
Rabkin, J G; Wagner, G J; Rabkin, R (1999) Testosterone therapy for human immunodeficiency virus-positive men with and without hypogonadism. J Clin Psychopharmacol 19:19-27
|
|
Maguen, S; Wagner, G J; Rabkin, J G (1998) Long-term testosterone therapy in HIV-positive men: side-effects and maintenance of clinical benefit. AIDS 12:327-8
|
|
Wagner, G; Rabkin, J; Rabkin, R (1998) Exercise as a mediator of psychological and nutritional effects of testosterone therapy in HIV+ men. Med Sci Sports Exerc 30:811-7
|
|
Wagner, G J; Rabkin, J G; Rabkin, R (1998) Testosterone as a treatment for fatigue in HIV+ men. Gen Hosp Psychiatry 20:209-13
|
|
Wagner, G J; Rabkin, J G (1998) Testosterone therapy for clinical symptoms of hypogonadism in eugonadal men with AIDS. Int J STD AIDS 9:41-4
|
|
Wagner, G J; Maguen, S; Rabkin, J G (1998) Ethnic differences in response to fluoxetine in a controlled trial with depressed HIV-positive patients. Psychiatr Serv 49:239-40
|
|
Wagner, G J; Rabkin, J G (1998) Testosterone, illness progression, and megestrol use in HIV-positive men. J Acquir Immune Defic Syndr Hum Retrovirol 17:179-80
|
Showing the most recent 10 out of 13 publications
